Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Chimeric Therapeutics Ltd
ASX:CHM

Watchlist Manager
Chimeric Therapeutics Ltd Logo
Chimeric Therapeutics Ltd
ASX:CHM
Watchlist
Price: 0.002 AUD Market Closed
Market Cap: AU$7.3m
Write Note Create Alert Ask AI

Chimeric Therapeutics Ltd
Investor Relations

Chimeric Therapeutics Ltd. develops Chlorotixin CAR-T technology based cell therapies for the curation of solid tumors. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-01-18. The firm's technology known as CLTX-CAR T, uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells. The CAR T cell is an immune T cell taken from a patient’s blood which is sent to a lab where it is re-programmed to become a charged guided missile, to seek out a specific target on the surface of a cancer cell.

Show more
Loading
CHM
S&P/ASX 300
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD
Founder & Executive Chairman
No Bio Available
Mr. Phillip Allen Hains BBus(Acc), C.A., M.B.A.
CFO, Joint Company Secretary & Director
No Bio Available
Dr. Rebecca McQualter
Chief Operating Officer
No Bio Available
Mr. Jason B. Litten M.D.
Chief Medical Officer
No Bio Available
Mr. Kelly R. Thornburg
VP & Head of Quality
No Bio Available
Mr. Nathan Jong C.A.
Joint Company Secretary
No Bio Available

Contacts

Address
VICTORIA
Melbourne
Level 3, 62 Lygon Street, Carlton South
Contacts
www.chimerictherapeutics.com
sparklesyt

See Also

Summary
CHM intrinsic value, competitors valuation, and company profile.
DCF Valuation
CHM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CHM stock valuation using valuation multiples.
Wall Street Estimates
CHM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CHM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 315,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.